Clinical Research Directory
Browse clinical research sites, groups, and studies.
Withania Somnifera for Moderate-to-Severe Persistent Asthma
Sponsor: Aligarh Muslim University
Summary
This randomized, double-blind, placebo-controlled study evaluated Withania somnifera root powder as a complementary therapy in adults with moderate-to-severe persistent asthma receiving standard asthma treatment. Participants were assigned to standard treatment alone, standard treatment plus placebo, or standard treatment plus Withania somnifera root powder for 10 weeks. Lung function, asthma control, quality of life, systemic oxidative stress, and inflammatory and allergic biomarkers were assessed before and after the intervention to evaluate the potential additional benefits of Withania somnifera in asthma management.
Official title: Study on Anti-oxidative and Anti-Inflammatory Effects of Certain Herbs for Inflammatory Lung Diseases
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-02-15
Completion Date
2026-06-15
Last Updated
2026-08-26
Healthy Volunteers
No
Conditions
Interventions
Withania somnifera Root Powder
Withania somnifera root powder was administered orally in capsule form at a dose of 300 mg twice daily (total daily dose 600 mg) for 10 weeks, in addition to standard asthma treatment.
Starch Placebo Capsules
Starch placebo capsules were administered orally for 10 weeks in addition to standard asthma treatment.
Standard Asthma Treatment
Standard asthma treatment included inhaled corticosteroid (fluticasone) and long-acting beta-agonist therapy according to the treating physician's prescription.
Locations (1)
Aligarh Muslim University
Aligarh, Uttar Pradesh, India